Table 5.
Study | Validation performance—reported from study | Validation performance—NYU data | Performance difference between study validation performance and NYU original validation performance | Validation performance—NYU retrained (95% CI) | Performance difference between study validation performance and NYU retrained validation performance | NYU deviations from original |
Gong et al5 | Cohort 1: AUROC=0.85 | AUROC=0.59 | AUROC difference=0.26 | AUROC=0.68 (0.64 to 0.74) |
AUROC difference=0.17 | PaO2 data not available. Target excluded |
Gong et al5 | Cohort 2: AUROC=0.75 | AUROC=0.60 | AUROC difference=0.16 | AUROC=0.68 (0.64 to 0.74) |
AUROC difference=0.07 | PaO2 data not available. Target excluded |
Zhou et al8 | AUROC=0.88 | AUROC=0.74 | AUROC difference=0.14 | AUROC=0.75 (0.71 to 0.78) |
AUROC difference=0.14 | ‘Severe respiratory distress’ target not characterisable. Target excluded |
Zou et al9 | * | AUROC=0.70 | * | AUROC=0.72 (0.67 to 0.77) | * | Altered mental status measured as Glasgow Coma Score <15 |
Mean AUROC=0.83 | Mean AUROC=0.66 | Mean AUROC difference=0.19 | Mean AUROC=0.71 | Mean AUROC difference=0.13 |
*Value unavailable because authors did not provide an AUROC value when reporting validation performance.
AUROC, area under the receiver–operator curve; NYU, New York University; PaO2, partial pressure of oxygen.